A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

I8F-MC-GPGB -

The purpose of this study is to evaluate the efficacy of the study drug tirzepatide in participants with type 2 diabetes mellitus.

Trial Summary

Age Range
18 - 75 years
Conditions the trial is for
Type 2 Diabetes
What the trial is testing?
Dulaglutide, Tirzepatide
Could I receive a Placebo?
Yes
Enrollment Goal
318
Trial Dates
May 24, 2017 - Aug 1, 2018
How long will I be in the trial?
Your participation could last up to 26 weeks and include approximately 16 visits to the study center.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.